))
Nik Sharma & Mo Alomari: The Future of Tech Bio: | Episode 23
Manage episode 409190162 series 2980456
Content provided by Aarish Shah - EmergeONE. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Aarish Shah - EmergeONE or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode of Nothing Ventured, we delve into the world of tech bio with co-founders Nik Sharma and Mo Alomari from BioCortex. They discuss reflecting biology in silico, NASA-inspired strategies, and the importance of trust in co-founder relationships. Learn how BioCortex is revolutionizing therapeutic development with insights backed by Hoxton and Sofinova. Tune in for a deep dive into the intersection of technology and biotech with these innovative minds. 🕒 Time stamps - 01:01 - Introducing Guests Nick Sharma and Mo Al-Omari 01:55 - Emulation vs. Simulation in Tech Bio 02:16 - BioCortex: A Tech Bio Company Overview 02:27 - Founders' Backgrounds and Expertise 03:09 - BioCortex's Vision and Technology 03:33 - Personalizing Medication Efficacy with BioCortex 04:15 - Broader Applications of BioCortex Technology 04:31 - Carbon Knowledge and Carbon Mirror Technologies 05:03 - Emulation in Aerospace Applied to Biology 05:38 - Conceptualizing Human Biology for Drug Interaction 06:25 - Understanding Emulation and Simulation 07:04 - The Role of Bacteria in Drug Efficacy 07:34 - The Distinction Between Emulation and Simulation 08:34 - NASA's Use of Emulation 09:10 - The Importance of Understanding Mechanisms in Medicine 09:43 - The Reality of Drug Response Rates 10:21 - BioCortex's Approach to AI and Emulation 11:01 - The Co-Founders' Meeting and Collaboration 11:29 - The Genesis of BioCortex 12:00 - Addressing Motor Neurone Disease Communication 13:02 - The Evolution of Nick and Mo's Partnership 13:38 - The Challenge of Modeling Bacteria 14:02 - The Solution to Modeling Complex Biological Systems 14:58 - The Importance of Trust in Co-Founder Relationships 16:01 - The Dynamics of Co-Founder and VC Relationships 16:53 - Defining Tech Bio vs. Biotech 17:36 - Capital Efficiency and Growth Concerns 18:11 - Maintaining Culture and Focus in a Startup 19:08 - The Challenge of Diverse Disciplines in a Tech Bio Team 20:00 - The Impact of Remote Work on Team Dynamics 21:19 - The Importance of Security and Tools for Remote Work 22:04 - The Benefits of In-Person and Remote Work Balance 22:44 - The Diverse Expertise within the BioCortex Team 00:23:27 - The Future of Tech Bio and Biotech Industry
179 episodes
Share
